All questionsPharmacology: Otezla (apremilast), all indications4 questions · 2 sourcesMechanismHow does Otezla work (mechanism of action)?“Apremilast is an oral small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP). PDE4 inhibition results in increased intracellular cAMP levels. The specific mechanism(s) by which apremilast exerts its therapeutic action is not well defined.” (opens the source at this quote in a new tab)CopyFlag“In clinical studies, apremilast decreased IL-17, IL-22 and TNF-alpha levels circulating in blood and reduced expression of these pro-inflammatory cytokine genes in skin. The clinical implications of these pharmacodynamic responses remain unclear.” (opens the source at this quote in a new tab)CopyFlag“PDE4 is a cAMP-specific PDE that has been shown to degrade cAMP to AMP in inflammatory cells 3,7” (opens the source at this quote in a new tab)CopyFlagPharmacokineticsHow is Otezla metabolized and eliminated?“Following oral administration in humans, apremilast is a major circulating component (45%) followed by inactive metabolite M12 (39%), a glucuronide conjugate of O-demethylated apremilast. It is extensively metabolized in humans with up to 23 metabolites identified in plasma, urine and feces. Apremilast is metabolized by both cytochrome (CYP) oxidative metabolism with subsequent glucuronidation and non-CYP mediated hydrolysis. In vitro, CYP metabolism of apremilast is primarily mediated by CYP3A4, with minor contributions from CYP1A2 and CYP2A6.” (opens the source at this quote in a new tab)CopyFlag“Following oral administration of radiolabeled apremilast, about 58% and 39% of the radioactivity is recovered in urine and feces, respectively, with about 3% and 7% of the radioactive dose recovered as apremilast in urine and feces, respectively.” (opens the source at this quote in a new tab)CopyFlagHow long does Otezla stay in your system (half-life)?“The plasma clearance of apremilast is about 10 L/hr in healthy subjects, with a terminal elimination half-life of approximately 6-9 hours.” (opens the source at this quote in a new tab)CopyFlag“OTEZLA when taken orally is absorbed with an absolute bioavailability of ~73%, with peak plasma concentrations (Cmax) occurring at a median time (tmax) of ~2.5 hours.” (opens the source at this quote in a new tab)CopyFlag“OTEZLA XR when taken orally is absorbed with peak plasma concentrations (Cmax) occurring at a median time (tmax) of ~6 hours.” (opens the source at this quote in a new tab)CopyFlagComponentsWhat are the inactive ingredients in Otezla and Otezla XR tablets?“OTEZLA (apremilast) tablets are supplied in 10 mg, 20 mg, and 30 mg strengths for oral administration. Each tablet contains apremilast as the active ingredient and the following inactive ingredients: croscarmellose sodium, iron oxide red, iron oxide yellow (20 and 30 mg only), iron oxide black (30 mg only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide.” (opens the source at this quote in a new tab)CopyFlag“OTEZLA XR (apremilast) extended-release tablets are supplied in a 75 mg strength for oral administration. Each tablet contains apremilast as the active ingredient and the following inactive ingredients: cellulose acetate, colloidal silicon dioxide, ferrosoferric oxide, hydroxypropyl methylcellulose acetate succinate, hypromellose, iron oxide red, magnesium stearate, mannitol, microcrystalline cellulose, polyethylene glycol, polyethylene oxide, sodium chloride, titanium dioxide.” (opens the source at this quote in a new tab)CopyFlag